Black Rock Inc. In Med Pharmaceuticals Inc. Transaction History

Black Rock Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	BUY	$1.32 - $7.95 $66 - $397	50 New	50 $0

790K

Ticker INM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 908,761
Market Cap $2.88M
Description
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.